ContributorsPublishersAdvertisers

Leveraging Biomarkers in Endometrial Cancer Requires Careful Integration, More Research

onclive.com
 2022-01-27

Casey M. Cosgrove, MD, discussed the current state of biomarkers in the realm of endometrial cancer and how they may be optimally leveraged for prognostic and predictive purposes. Biomarkers such as mismatch repair deficiency (dMMR), microsatellite instability (MSI), p53 positivity, and POLE mutations possess the potential to inform treatment...

www.onclive.com

Comments / 0

Comments / 0